Clinical Domain Working Groups
Cardiomyopathy Variant Curation Expert Panel
Membership DocumentsScope of Work
Adapt ACMG classification criteria for genes associated with inherited cardiomyopathy
- Phase 1: MYH7 for HCM, DCM.
- Phase 2: Evaluate applicability of the rules developed for MYH7 for other HCM genes, including MYBPC3, MYL2, MYL3, TNNT2, TPM1, TNNI3, ACTC1.
- Future Aims: Adapting rules and specifications for other gene with a definitive association with hypertrophic cardiomyopathy as determined from the Hereditary Cardiovascular Diseases GCEP.
Expert Panel Status
Documents
-
ClinGen Cardiomyopathy Variant Curation Expert Panel COIConflict Of Interest (COI) - August 26, 2022
-
-
ClinGen Cardiomyopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1Curation Activity Procedures - June 25, 2017 Archived Document
Expert Panel Membership
Membership spans many fields, including genetics, medical, academia, and industry.
Coordinators
Members
Chairs
Coordinators
Please contact a coordinator if you have questions.
Lucas Bronicki, PhD, FACMG, DABMGG
Haley Garrett, MPH
Linnea M. Baudhuin, PhD, FACMG
Alizabeth Berg, MS, LCGC
Lauren Boucher, CGC
William Charles Hankey, PhD
Natasha Henden, BMLS, PgDip BioMed Sci
Tami Johnston, MS, LCGC
Melissa Kelly MS, CGC
Ana Morales, MS, LGC
Cherith Somerville, MS
Kate Thomson, PhD, BSc, FRCPath
Matteo Vatta, PhD, FACMG